(Q39348373)

11 September 2017

title

Acquired resistance to peloruside A and laulimalide is associated with downregulation of vimentin in human ovarian carcinoma cells (English)

1 reference

11 September 2017

1 reference

ChEBI release 2020-05-28

1 reference

Arun Kanakkanthara

1

1 reference

11 September 2017

Pisana Rawson

series ordinal

2

1 reference

11 September 2017

Peter T Northcote

series ordinal

3

1 reference

11 September 2017

John H Miller

series ordinal

4

1 reference

11 September 2017

publication date

15 May 2012

1 reference

11 September 2017

published in

Pharmaceutical Research

1 reference

11 September 2017

volume

29

1 reference

11 September 2017

issue

11

1 reference

11 September 2017

page(s)

3022-3032

1 reference

Molecular and cellular biology of intermediate filaments

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Widespread occurrence of intermediate-sized filaments of the vimentin-type in cultured cells from diverse vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

A direct interaction between actin and vimentin filaments mediated by the tail domain of vimentin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Vimentin in cancer and its potential as a molecular target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Vimentin is a novel AKT1 target mediating motility and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Examining the relationship between cancer invasion/metastasis and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Microtubule-binding agents: a dynamic field of cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Microtubules and resistance to tubulin-binding agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Cytoskeletal reorganization during process of apoptosis induced by cytostatic drugs in K-562 and HL-60 leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Expression of cytokeratin confers multiple drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

βII-tubulin and βIII-tubulin mediate sensitivity to peloruside A and laulimalide, but not paclitaxel or vinblastine, in human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

The function of intermediate filaments in cell shape and cytoskeletal integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

The Raf-1 kinase associates with vimentin kinases and regulates the structure of vimentin filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Phosphorylation and reorganization of vimentin by p21-activated kinase (PAK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Aurora-B regulates the cleavage furrow-specific vimentin phosphorylation in the cytokinetic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Calyculin A-induced vimentin phosphorylation sequesters 14-3-3 and displaces other 14-3-3 partners in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Correlation between decreased apoptosis and multidrug resistance (MDR) in murine leukemic T cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Peloruside A enhances apoptosis in H-ras-transformed cells and is cytotoxic to proliferating T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Changes in nuclear morphology during apoptosis correlate with vimentin cleavage by different caspases located either upstream or downstream of Bcl-2 action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Retracted: Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Paclitaxel effects on the proteome of HL-60 promyelocytic leukemic cells: comparison to peloruside A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0773-X

Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity

21 January 2018

1 reference

12 December 2020

Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.

1 reference

12 December 2020

A novel taxol-induced vimentin phosphorylation and stabilization revealed by studies on stable microtubules and vimentin intermediate filaments.

1 reference

12 December 2020

Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.

1 reference

12 December 2020

A microtubule-interacting protein involved in coalignment of vimentin intermediate filaments with microtubules

1 reference

12 December 2020

Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients

1 reference

12 December 2020

Estimation of taxol influence on changes in tubulin and vimentin systems in K-562 and HL-60 cell lines by immunofluorescence microscopy.

1 reference

12 December 2020

Apoptosis-associated proteolysis of vimentin in human prostate epithelial tumor cells

1 reference

12 December 2020

10.1007/S11095-012-0773-X

Identifiers

DOI

1 reference

11 September 2017

1 reference